An observational study of Korean herbal medicine and Electroacupuncture Combination Therapy for Mild Cognitive Impairment patients.

Daejeon Korean Medicine Hospital of Daejeon University0 个研究点目标入组 6 人开始时间: 待定最近更新: 2022年11月28日

试验速览

暂无简介。

•1. Aged 45 to 84
•2. Diagnosed with mild cognitive impairment based on DSM-5 criteria
•3. Clinical Dementia Rating of 0.5
•4. MoCA-K 22 points or less.
•5. Patients who understand the questionnaire himself/herself or with the help of caregivers.
•6. Participants who voluntarily signed an informed consent form by himself/herself or a legal representative.

•1. Patients with encephalopathy, brain damage, or mental retardation that can influence cognitive function
•2. Histories of brain diseases such as Huntington's disease, normal hydrocephalus, or brain tumors
•3. Gastric, endocrine, or cardiovascular diseases that are not controlled by diet or medication
•4. Diabetes that is not controlled by hypoglycemic agents or insulin
•5. Severe liver disease or severe renal disease that requires dialysis (e.g. over 2 times the upper reference limit of AST, ALT, ?-GTP at screening)
•6. Aplastic anemia or malignant disease such as cancer.
•7. Seriously unstable medical conditions (the investigator will decide based on vital signs, laboratory test results, etc.)
•8. Diagnosed with psychiatric disorders based on DSM-5 criteria (e.g histories of major psychiatric disorders such as schizophrenia, bipolar disorder, delusional disorder, depressive disorders, or alcohol or substance use disorder)
•9. Fertile women
•10. Not understand an informed consent form or hard to participate in the study due to mental retardation, emotional or intellectual issues
•11. Participants with blindness, hearing loss, or severe language disorders have difficulty in examination
•12. Not appropriate to participate in this study depending on decision of investigators

发起方

Daejeon Korean Medicine Hospital of Daejeon University